Increased Serum Lactate Dehydrongenase Should Be Included Among the Variables That Define Very-High-Risk Multiple Myeloma-Reference-Cited by-同舟云学术

Increased Serum Lactate Dehydrongenase Should Be Included Among the Variables That Define Very-High-Risk Multiple Myeloma

Published:2011-10 Issue:5 Volume:11 Page:409-413
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Gkotzamanidou Maria,Kastritis Efstathios,Gavriatopoulou Maria Roussou Magdalini Migkou Mari,Nikitas Nikitas,Gika Dimitra,Mparmparousi Despina,Matsouka Charis,Terpos Evangelos,Dimopoulos Meletios A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

2. Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG);Kastritis;Leukemia,2009

3. Multiple myeloma;Palumbo;N Engl J Med,2011

4. Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p);Avet-Loiseau;J Clin Oncol,2010

5. Ultra high-risk myeloma;Avet-Loiseau;Hematology Am Soc Hematol Educ Program,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC translocation is a valuable marker for the development and relapse of extramedullary disease in multiple myeloma;European Journal of Haematology;2024-08-27

2. Comprehensive analysis and establishment of a prognostic model based on non-genetic predictors in multiple myeloma1;Cancer Biomarkers;2023-09-05

3. Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment;Frontiers in Oncology;2023-04-06

4. Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era;Cancer Medicine;2023-04

5. Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification;Frontiers in Public Health;2022-10-17